-
About FDA
-
Academia MOUs
|
MOU No. |
Purpose |
Parties |
FDALead |
Effective |
Expiration |
| Establishes terms of collaboration between FDA and UMD to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships. | University of MD | OC Judy Blumenthal (202) 260-0677 |
09-04-2002 |
Indefinite |
|
| Establishes terms of collaboration between FDA and VA Polytechnic Institute to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships. | University of Houston | CDRH Michelle Chenault (240) 276-3815 |
03-29-2003 |
Indefinite |
|
| Establishes terms of collaboration between FDA and VA Polytechnic Institute to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships. | VA Polytechnic Institute |
OC Mary Poos (301) 827-2825 |
03-13-2003 |
Indefinite |
|
| Establishes terms of collaboration between FDA and Howard University to support shared interest in scientific progress affecting human and animal health and medicine through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships. | Howard University | OC Mary Poos (301) 827-2825 |
05-29-2003 |
Indefinite |
|
| Establishes a framework for collaborative research and development and emergency triage response efforts on the subject of Homeland Security. | University of CA, Lawrence Livermore National Laboratory | ORA Jeanne Roman (301) 827-0947 |
04-14-2004 |
Indefinite |
|
| Establishes a framework for collaborative partnership on mutually agreed activities in the areas of scientific research and education. | Harvard/MIT | OC/CDER Mary Poos (301) 827-2825 |
03-29-2004 |
03-28-2009 |
|
| To establish terms of collaboration between FDA and BWH to support shared interests and to begin the initiative "The FDA Brigham Elective Program for Residents in the Department of Medicine." | Brigham and Women's Hospital | CDRH Nancy Pluhowski (301) 827-2890 |
05-09-2006 |
|
|
| Establishes collaboration between FDA, Duke University, and Duke University Health System, Inc. in sharing scientific information. | Duke University Duke University Health System, Inc. |
CDRH Nancy Pluhowski (301) 827-2890 |
09-18-2006 |
Indefinite |
|
| FDA and Duke agree to collaborate through steering committees and technical working groups, to develop strategic plans, set priorities, and leverage resources and expertise from multiple sources, including the private sector, toward the goals of identifying indicators of cardiovascular risk, predicting adverse cardiovascular events associated with therapeutic interventions, improving the clinical utility of biomarker technologies as diagnostic and assessment tools that facilitate the development of safer and more effective cardiovascular therapies, diagnostic, and assessment tools. | Duke University | OC Mary Poos (301) 827-2825 |
08-15-2006 |
08-15-2009 |
|
| Establishes terms of collaboration between FDA/CBER and Yokohama City University in CBER's Collaborative Scientific Training Program (CSTP) which targets development of scientific tools for biological product evaluation and regulation. | Yokohama City University | CBER Dano Murphy (301) 827-0801 |
12-21-06 |
12-31-09 |
|
| Establishes terms of collaboration between FDA and the University of California, Davis Campus, to support shared interests that can be pursued through a variety of programs. | The University of California, Davis Campus | OC Mary Poos (301) 827-2825 |
12-07-07 |
12-07-12 |
|
| To establish terms of collaboration between FDA and Duke, as a part of FDA's Critical Path Initiative. This MOU will serve as the basis of a Public Private Partnership hosted by Duke to systematically modernize the clinical trial process. | Duke University | OC Melissa Robb (301) 827-1516 |
09-22-2007 |
Indefinite |
|
| FDA and the Alliance for NanoHealth (ANH) agree to collaborate with multiple orginizations facilitated and coordinated through the ANH, to improve the safety and efficacy of nanoengineered products and speed their delivery to the patients who need them and the consumers who use them. | Baylor College of Medicine The University of Texas M.D. Anderson Cancer Center Rice University University of Houston The University of Texas Health Science Center at Houston Texas A&M Health Science Center The University of Texas Medical Branch at Galveston The Methodist Hospital Research Institute |
OC Wendy R. Sanhai, Ph.D. |
02-12-2009 |
02-12-2011 |
|
|
225-07-8008 replaces 225-02-8000 |
To establish collaboration in the areas of advanced scientific training, information exchange and stimulation of cooperative research activities in biotechnology, bioethics, and nanotechnology, particularly with the Institute of NanoBioTechnology. | John Hopkins University | OC Mary Poos (301) 827-2825 |
10-11-2007 |
Indefinite |
| Establishes terms of collaboration between FDA and the University System of MD to support their shared interest in scientific progress in the diverse disciplines that directly and indirectly affect human and animal health medicine. | University System of MD | OC Mary Poos (301) 827-2825 |
07-12-2007 |
07-12-2012 |
|
| IL Inst. Tech., participation in short courses, workshops, & training programs in food safety and technology. | IL Inst. Tech | CFSAN Don Zink (301) 436-1693 |
09-03-1993 |
Indefinite |
|
| Univ of MD and FDA will conduct collaborative research dealing with mission-related activities under the creation of the Joint Institute for Food Safety and Applied Nutrition (JIFSAN). | University of MD | CFSAN Beth Calvey (301) 436-1981 |
04-15-1996 |
04-18-2006 |
|
| Establishes terms of collaboration between FDA and UMBC to support collaboration on specific projects related to biotechnology process validation, but can serve as a basis for future collaboration in other areas. | University of MD Baltimore County | CBER Dr. Kurt Brorson (301) 827-0661 |
07-25-2003 |
Indefinite |
-
-